Full Fed. Circ. Limits On-Sale Bar's Reach In Angiomax Case
The full Federal Circuit ruled Monday that the on-sale bar invalidating a patent is triggered only by a transaction that "bears the general hallmarks of a sale," holding that The Medicines...To view the full article, register now.
Already a subscriber? Click here to view full article